Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Anal Chim Acta ; 1142: 201-210, 2021 Jan 15.
Article in English | MEDLINE | ID: mdl-33280698

ABSTRACT

There is an increasing interest in determining the concentration of furanic compounds naturally formed in food aqueous matrices, by in situ, fast and low-cost methods. A sensor presenting such characteristics is here proposed, and characterized. It is based on a molecularly imprinted polymer (MIP) as a receptor with electrochemical transduction on a screen printed cell (SPC). The molecularly imprinted polymer has been developed for a particular furanic derivative, 2-furaldehyde (2-FAL). The detection bases on the reduction of 2-FAL selectively adsorbed on the polymer layer in contact with the working electrode. The polymer layer is simply formed by in situ polymerization, directly over the SPC and it was characterized by IR, SEM and electrochemical methods. Even if based on an easy and fast preparation procedure, the layer sufficiently adheres to the cell surface giving a reusable sensor. Square wave voltammetry (SWV) was applied as the signal acquisition method. The sensor performance in aqueous solution (NaCl 0.1 M) was tested, obtaining that the dose-response curve is fitted by the Langmuir adsorption isotherm. The sensitivity, and so the limit of detection, were noticeably improved by a chemometric approach based on the Design of experiment method. (optimized conditions: Estep = 0.03 V, Epulse = 0.066 V, f = 31 s-1). In water solution at pH around neutrality the dynamic range was from about 50 µM to 20 mM. Similar results were obtained for a white wine containing 12% ethanol, which has been considered as a typical example of beverage possibly containing furhaldehydes. The higher limit of quantification can be modulated by the amount of MIP deposited, while the lower detection limit by the conditions of the electrochemical measurement.


Subject(s)
Molecular Imprinting , Beverages , Electrochemical Techniques , Electrodes , Furaldehyde , Limit of Detection , Molecularly Imprinted Polymers
2.
Restor Neurol Neurosci ; 35(6): 583-599, 2017.
Article in English | MEDLINE | ID: mdl-29172009

ABSTRACT

BACKGROUND: Spinal cord injury (SCI) is a debilitating condition characterized by a complex of neurological dysfunctions ranging from loss of sensation to partial or complete limb paralysis. Recently, we reported that intravenous administration of neural precursors physiologically releasing erythropoietin (namely Er-NPCs) enhances functional recovery in animals following contusive spinal cord injury through the counteraction of secondary degeneration. Er-NPCs reached and accumulated at the lesion edges, where they survived throughout the prolonged period of observation and differentiated mostly into cholinergic neuron-like cells. OBJECTIVE: The aim of this study was to investigate the potential reparative and regenerative properties of Er-NPCs in a mouse experimental model of traumatic spinal cord injury. METHODS AND RESULTS: We report that Er-NPCs favoured the preservation of axonal myelin and strongly promoted the regrowth across the lesion site of monoaminergic and chatecolaminergic fibers that reached the distal portions of the injured cord. The use of an anterograde tracer transported by the regenerating axons allowed us to assess the extent of such a process. We show that axonal fluoro-ruby labelling was practically absent in saline-treated mice, while it resulted very significant in Er-NPCs transplanted animals. CONCLUSION: Our study shows that Er-NPCs promoted recovery of function after spinal cord injury, and that this is accompanied by preservation of myelination and strong re-innervation of the distal cord. Thus, regenerated axons may have contributed to the enhanced recovery of function after SCI.


Subject(s)
Erythropoietin/metabolism , Nerve Regeneration/physiology , Recovery of Function/physiology , Spinal Cord Injuries/surgery , Stem Cell Transplantation/methods , Animals , Choline O-Acetyltransferase/metabolism , Dextrans/metabolism , Disease Models, Animal , Erythropoietin/therapeutic use , Fluorescent Dyes/administration & dosage , GAP-43 Protein/metabolism , Locomotion/physiology , Male , Mice , Microtubule-Associated Proteins/metabolism , Myelin Sheath/drug effects , Myelin Sheath/pathology , Nerve Regeneration/drug effects , Organic Chemicals/administration & dosage , Recovery of Function/drug effects , Rhodamines/metabolism , Serotonin/metabolism , Spinal Cord Injuries/pathology , Tubulin/metabolism , Tyrosine 3-Monooxygenase/metabolism
3.
J Colloid Interface Sci ; 498: 271-281, 2017 Jul 15.
Article in English | MEDLINE | ID: mdl-28342310

ABSTRACT

The synthesis of Ag nanoparticles from Ag+ has been investigated, with pectin acting both as reductant and coating.∼100% Ag+ to Ag(0) one-pot conversion was obtained, yielding p-AgNP, i.e. an aqueous solution of pectin-coated spherical Ag nanoparticles (d=8.0±2.6nm), with a<1ppm concentration of free Ag+ cation. Despite the low free Ag+ concentration and low Ag+ release with time, the nature of the coating allows p-AgNP to exert excellent antibacterial and antibiofilm actions, comparable to those of ionic silver, tested on E. coli (Gram-) and S. epidermidis (Gram+) both on planctonic cells and on pre- and post-biofilm formation conditions. Moreover, p-AgNP were tested on fibroblasts: not only p-AgNP were found to be cytocompatible but also revealed capable of promoting fibroblasts proliferation and to be effective for wound healing on model cultures. The antibacterial activity and the wound healing ability of silver nanoparticles are two apparently irreconcilable properties, as the former usually requires a high sustained Ag+ release while the latter requires low Ag+ concentration. p-AgNP represents an excellent compromise between opposite requirements, candidating as an efficient medication for repairing wounds and/or to treat vulnerable surgical site tissues, including the pre-treatment of implants as an effective prophylaxis in implant surgery.


Subject(s)
Anti-Bacterial Agents/chemistry , Biofilms/drug effects , Metal Nanoparticles/chemistry , Pectins/chemistry , Silver/chemistry , Wound Healing/drug effects , Anti-Bacterial Agents/pharmacology , Cell Proliferation/drug effects , Cell Survival/drug effects , Escherichia coli/drug effects , Fibroblasts/cytology , Fibroblasts/drug effects , Humans , Particle Size , Pectins/pharmacology , Plankton/cytology , Plankton/drug effects , Silver/pharmacology , Silver Nitrate/pharmacology , Staphylococcus epidermidis/drug effects , Surface Properties
4.
Anal Bioanal Chem ; 405(11): 3559-70, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23180087

ABSTRACT

New methods for determination of explosive substances as, for example, 2,4,6-trinitrotoluene (TNT), in a rapid way and at low cost are highly required. An electrochemical platform has been here developed with good characteristics of low dimension, fast response, low cost, and high selectivity. It is based on a commercially available screen printed cell with graphite ink working and auxiliary electrodes and a silver ink quasi-reference electrode. The whole cell is covered with a thick layer of cation exchanging acrylic polymer molecularly imprinted with 2,4,6-trinitrotoluene. The polymeric layer acts at the same time as electrolytic medium and selective receptor. It has been demonstrated that, in this medium, 2,4,6-trinitrotoluene is electroactive at graphite electrode, being reduced by a non-reversible reaction. The peak current (differential pulse voltammogram) is proportional to TNT concentration with limit of detection for TNT around 5 × 10(-7) M and linearity range up to 2 × 10(-5) M. The selectivity for TNT relative to other reducible compounds as, for example, nitroaromatic derivatives, and to other possible interfering substances, as negatively charged ions, is good. Measurements can be performed in not de-aerated solution and in small volumes (20 µl), so that the proposed platform is very promising for in situ determinations.

5.
Neuroscience ; 219: 290-301, 2012 Sep 06.
Article in English | MEDLINE | ID: mdl-22659566

ABSTRACT

Spinal cord injury (SCI) is a debilitating clinical condition, characterized by a complex of neurological dysfunctions. It has been shown in rats that the acute administration of recombinant human erythropoietin (rhEPO) following a contusive SCI improves the recovery of hindlimb motor function, as measured with the locomotor BBB (Basso, Beattie, Bresnahan) scale. This scale evaluates overall locomotor activity, without testing whether the rhEPO-induced motor recovery is due to a parallel recovery of sensory and/or motor pathways. Aim of the present study was to utilize an electrophysiological test to evaluate, in a rat model of contusive SCI, the transmission of both ascending and descending pathways across the damaged cord at 2, 5, 7, 11, and 30 days after lesion, in animals treated with rhEPO (n=25) vs saline solution (n=25). Motor potentials evoked by epicortical stimulation were recorded in the spinal cord, and sensory-evoked potentials evoked by spinal stimulation were recorded at the cortical level. In the same animals BBB score and immunocytochemical evaluation of the spinal segments caudal to the lesion were performed. In rhEPO-treated animals results show a better general improvement both in sensory and motor transmission through spared spinal pathways, supposedly via the reticulo-spinal system, with respect to saline controls. This improvement is most prominent at relatively early times. Overall these features show a parallel time course to the changes observed in BBB score, suggesting that EPO-mediated spared spinal cord pathways might contribute to the improvement in transmission which, in turn, might be responsible for the recovery of locomotor function.


Subject(s)
Erythropoietin/pharmacology , Neuroprotective Agents/pharmacology , Recovery of Function/drug effects , Spinal Cord Injuries/physiopathology , Animals , Contusions , Disease Models, Animal , Electrophysiology , Evoked Potentials, Motor/drug effects , Evoked Potentials, Somatosensory/drug effects , Female , Humans , Motor Activity/drug effects , Rats , Rats, Sprague-Dawley , Recombinant Proteins/pharmacology , Spinal Cord Injuries/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...